Scientists hunt for clues to drug resistance in breast cancer
NCT ID NCT04653740
First seen Mar 20, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study looks at why the drug Palbociclib stops working in some people with advanced breast cancer. Researchers will collect blood and breath samples from 25 women over time to track changes in their cancer. The goal is to find patterns that signal when the drug is losing its effect, which could help doctors switch treatments earlier.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
Conditions
Explore the condition pages connected to this study.